Back
Catalyst Pharmaceuticals Vs. Nektar Therapeutics Industry Stock Comparison
Sell
41
CPRX
Catalyst Pharmaceuticals
Last Price:
14.91
Seasonality Move:
2.11%
Sell
42
NKTR
Nektar Therapeutics
Last Price:
1.36
Seasonality Move:
-0.34%
Sell
41
Catalyst Pharmaceuticals (CPRX)
is a Sell
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $14.68. The Score for CPRX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
- The current Nektar Therapeutics [NKTR] share price is $1.32. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $14.68
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing selling pressure, which indicates risk of future bearish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $1.32
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight selling pressure.
CPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 41.25 | Sell |
| Chaikin Money Flow: | -560167 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.08 - 15.98) | Sell |
| Bollinger Bands (100): | (14.04 - 16.2) | Sell |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 55.17 | Buy |
| Chaikin Money Flow: | -263292 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.98 - 1.46) | Buy |
| Bollinger Bands (100): | (0.47 - 1.09) | Buy |
CPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.21 | Sell |
| 20-day SMA: | 15.4 | Sell |
| 50-day SMA: | 15.47 | Sell |
| 200-day SMA: | 14.2 | Buy |
| 8-day EMA: | 15.1 | Sell |
| 20-day EMA: | 15.36 | Sell |
| 50-day EMA: | 15.35 | Sell |
| 200-day EMA: | 14.58 | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.36 | Sell |
| 20-day SMA: | 1.31 | Buy |
| 50-day SMA: | 1.01 | Buy |
| 200-day SMA: | 0.68 | Buy |
| 8-day EMA: | 1.36 | Sell |
| 20-day EMA: | 1.29 | Buy |
| 50-day EMA: | 1.07 | Buy |
| 200-day EMA: | 0.97 | Buy |
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $0.43 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $0.06 per share.
Catalyst Pharmaceuticals Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||